AbTis

AbTis is a biotechnology company specializing in antibody-drug conjugation technology, with its own proprietary patents. Our product pipeline aims to enhance the safety and efficacy of current antibody-drug conjugates by applying AbTis linkers to mAbs. Our technology is applicable to natural antibodies, commercial antibodies, or novel antibodies under development, as it does not require mutation or engineering of the antibody itself. AbTis is one of the leading bioconjugation companies. We strive to create positive economic impact and long-term value for patients worldwide, improving quality of life.